Literature DB >> 14907459

The activities of 1-hydrazinophthalazine (Ba-5968); a hypotensive agent.

B N CRAVER, W BARRETT, A CAMERON, F F YONKMAN.   

Abstract

Entities:  

Keywords:  HYPOTENSION; SYMPATHOLYTICS/effects

Mesh:

Substances:

Year:  1951        PMID: 14907459     DOI: 10.1002/jps.3030401109

Source DB:  PubMed          Journal:  J Am Pharm Assoc Am Pharm Assoc


× No keyword cloud information.
  5 in total

1.  [Effect of peroral prolonged therapy with 1,4-dihydrazinophthalazine on circulation and reflex changes in dogs].

Authors:  V EHRLICH; K FRONKOVA; L SLEGR
Journal:  Arch Kreislaufforsch       Date:  1958-09

2.  Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.

Authors:  G G ROWE; J H HUSTON; G M MAXWELL; A P CROSLEY; C W CRUMPTON
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

3.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

4.  Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline).

Authors:  E L WILKINSON; H BACKMAN; H H HECHT
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

5.  Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.

Authors:  N S ASSALI; S KAPLAN; S OIGHENSTEIN; R SUYEMOTO
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.